DR
Schedule 13G filing
mDR Ltd disclosed a 10% stake in GDTC
mDR Ltd reported owning 10% of CytoMed Therapeutics Ltd (GDTC) (1,191,523 shares) in a Schedule 13G filed Oct 23, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 23, 2026
- Source
- Schedule 13G
More GDTC insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.